Procter & Gamble (PG) Aandelenoverzicht
The Procter & Gamble Company levert wereldwijd verpakte consumptiegoederen onder merknaam. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 5/6 |
Beloningen
Risicoanalyse
PG Community Fair Values
Create NarrativeSee what 564 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
The Procter & Gamble Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$141.57 |
| 52 Week Hoogtepunt | US$170.99 |
| 52 Week Laag | US$137.62 |
| Bèta | 0.40 |
| 1 maand verandering | -1.26% |
| 3 maanden verandering | -11.56% |
| 1 Jaar Verandering | -13.30% |
| 3 jaar verandering | -7.57% |
| 5 jaar verandering | 2.59% |
| Verandering sinds IPO | 9,642.46% |
Recent nieuws en updates
Recent updates
Narratiefupdate • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Seeking Alpha • Apr 25
Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold
Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Nieuw narratief • Apr 24
Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples
Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.Narratiefupdate • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Narratiefupdate • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Narratiefupdate • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Narratiefupdate • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Narratiefupdate • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Narratiefupdate • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Narratiefupdate • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Narratiefupdate • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Narratiefupdate • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Narratiefupdate • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Narratiefupdate • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Narratiefupdate • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Narratiefupdate • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Narratiefupdate • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Analyseartikel • Aug 06
The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...Nieuw narratief • Jul 21
Procter & Gamble: A Dividend Giant Facing Slowing Growth
United States: 48.21%1-Year Revenue Growth = 4.65%Analyseartikel • Jun 27
The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...Seeking Alpha • Apr 22
Procter & Gamble: Hold This Stodgy Stalwart
Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking AlphaRendement voor aandeelhouders
| PG | US Household Products | US Markt | |
|---|---|---|---|
| 7D | -3.3% | -3.0% | -0.9% |
| 1Y | -13.3% | -14.2% | 24.4% |
Rendement versus industrie: PG kwam overeen met de US Household Products industrie, die het afgelopen jaar een rendement opleverde van -14.2 %.
Rendement versus markt: PG presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 24.4 % opleverde.
Prijsvolatiliteit
| PG volatility | |
|---|---|
| PG Average Weekly Movement | 3.1% |
| Household Products Industry Average Movement | 3.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: PG heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van PG is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1837 | 109,000 | Shailesh Jejurikar | www.pginvestor.com |
The Procter & Gamble Company levert wereldwijd verpakte consumptiegoederen onder merknaam. Het bedrijf is actief in de segmenten Beauty, Grooming, Health Care, Fabric & Home Care en Baby, Feminine & Family Care. Het bedrijf biedt conditioners, shampoos, stylingproducten en behandelingen onder de merknamen Head & Shoulders, Herbal Essences, Pantene en Rejoice; antitranspiratiemiddelen, deodorants en producten voor persoonlijke reiniging onder de merknamen Native, Old Spice, Safeguard en Secret; en vochtinbrengende gezichtsreinigers, reinigingsmiddelen en behandelingen onder de merknamen Olay en SK-II.
The Procter & Gamble Company Samenvatting
| PG fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$332.31b |
| Inkomsten(TTM) | US$16.32b |
| Inkomsten(TTM) | US$86.72b |
20.2x
Koers/Winstverhouding3.8x
P/S-verhoudingIs PG overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| PG resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$86.72b |
| Kosten van inkomsten | US$42.51b |
| Brutowinst | US$44.21b |
| Overige uitgaven | US$27.89b |
| Inkomsten | US$16.32b |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
Jul 29, 2026
| Winst per aandeel (EPS) | 7.01 |
| Brutomarge | 50.98% |
| Nettowinstmarge | 18.82% |
| Schuld/Eigen Vermogen Verhouding | 67.7% |
Hoe presteerde PG op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
3.1%
Huidig dividendrendement61%
UitbetalingsratioBetaalt PG een betrouwbaar dividend?
Zie PG dividendgeschiedenis en benchmarks| Procter & Gamble dividenddata | |
|---|---|
| Ex Dividend Datum | Apr 24 2026 |
| Betaaldatum dividend | May 15 2026 |
| Dagen tot Ex-dividend | 22 days |
| Dagen tot dividendbetaaldatum | 1 day |
Betaalt PG een betrouwbaar dividend?
Zie PG dividendgeschiedenis en benchmarksBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/15 04:38 |
| Aandelenkoers aan het einde van de dag | 2026/05/15 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/06/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
The Procter & Gamble Company wordt gevolgd door 43 analisten. 21 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |